Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease

Baris Boyraz, Diane H. Moon, Matthew Segal, Maud Z. Muosieyiri, Asli Aykanat, Albert K. Tai, Patrick Cahan, Suneet Agarwal

Research output: Contribution to journalArticle

Abstract

The telomerase RNA component (TERC) is a critical determinant of cellular self-renewal. Poly(A)-specific ribonuclease (PARN) is required for posttranscriptional maturation of TERC. PARN mutations lead to incomplete 3 end processing and increased destruction of nascent TERC RNA transcripts, resulting in telomerase deficiency and telomere diseases. Here, we determined that overexpression of TERC increased telomere length in PARN-deficient cells and hypothesized that decreasing posttranscriptional 3 oligo-adenylation of TERC would counteract the deleterious effects of PARN mutations. Inhibition of the noncanonical poly(A) polymerase PAP-associated domain-containing 5 (PAPD5) increased TERC levels in PARN-mutant patient cells. PAPD5 inhibition was also associated with increases in TERC stability, telomerase activity, and telomere elongation. Our results demonstrate that manipulating posttranscriptional regulatory pathways may be a potential strategy to reverse the molecular hallmarks of telomere disease.

Original languageEnglish (US)
Pages (from-to)3377-3382
Number of pages6
JournalJournal of Clinical Investigation
Volume126
Issue number9
DOIs
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease'. Together they form a unique fingerprint.

  • Cite this

    Boyraz, B., Moon, D. H., Segal, M., Muosieyiri, M. Z., Aykanat, A., Tai, A. K., Cahan, P., & Agarwal, S. (2016). Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease. Journal of Clinical Investigation, 126(9), 3377-3382. https://doi.org/10.1172/JCI87547